🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-18
Trial ID
NCT07280494
Treatments Being Tested
To evaluate the tolerability and safety of SENL101 in patients with relapse...
Status
Recruiting
Location
Shanghai Ruijin Hospital
Start Date
2023-08-15
Trial ID
NCT06136364
Treatments Being Tested
Despite the use of monoclonal antibodies, checkpoint inhibitors, and bispec...
Status
Unknown
Location
The First Affiliated Hospital of USTC
Start Date
2023-09-01
Trial ID
NCT05979792
Treatments Being Tested
This study is a single-arm, open-label clinical investigation to evaluate t...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-07-30
Trial ID
NCT07511426
Treatments Being Tested
This study is a single-center, open, prospective single-arm clinical study ...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-12-31
Trial ID
NCT06720324
Treatments Being Tested
This study is an open, single-center, prospective clinical trial, with newl...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-15
Trial ID
NCT07476027
Treatments Being Tested
This is a single-arm, open-label, single-center, phase I study. The primary...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2023-06-26
Trial ID
NCT05923541
Treatments Being Tested
This is a single dose escalation study to evaluate the safety and clinical ...
Status
Unknown
Location
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Start Date
2020-01-22
Trial ID
NCT05127135
Treatments Being Tested
This is a phase I, interventional, single arm, open label, treatment study ...
Status
Unknown
Location
Hebei Yanda Lu Daopei Hospital
Start Date
2022-07-01
Trial ID
NCT05212584
Treatments Being Tested
To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-18
Trial ID
NCT07143929
Treatments Being Tested